Haleon PLC Sponsored ADR (NYSE:HLN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has been given an average rating of “Moderate Buy” by the eleven ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation, three have given a buy recommendation and two have given a strong buy recommendation to the company.

Several equities research analysts have commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Royal Bank Of Canada restated a “sector perform” rating on shares of Haleon in a research report on Tuesday, August 11th. Wall Street Zen upgraded Haleon from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Zacks Research raised shares of Haleon from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 19th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a report on Thursday, August 6th.

Haleon Price Performance

Shares of HLN stock opened at $9.59 on Thursday. The firm has a market capitalization of $42.18 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 2.14 and a beta of 0.12. Haleon has a fifty-two week low of $8.65 and a fifty-two week high of $11.28. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.52 and a current ratio of 0.69. The stock’s 50-day simple moving average is $9.88 and its 200-day simple moving average is $9.74.

Haleon Cuts Dividend

The business also recently declared a dividend, which will be paid on Thursday, September 17th. Investors of record on Friday, August 14th will be given a dividend of $0.0642 per share. This represents a dividend yield of 132.0%. The ex-dividend date is Friday, August 14th. Haleon’s dividend payout ratio is 30.77%.

Institutional Investors Weigh In On Haleon

Several institutional investors have recently bought and sold shares of the company. Parkside Financial Bank & Trust increased its stake in Haleon by 101.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after buying an additional 1,433 shares in the last quarter. Western Wealth Management LLC purchased a new position in shares of Haleon in the first quarter valued at approximately $29,000. Annis Gardner Whiting Capital Advisors LLC boosted its stake in shares of Haleon by 402.0% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock worth $30,000 after acquiring an additional 2,404 shares during the last quarter. Geneos Wealth Management Inc. increased its position in shares of Haleon by 33.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after purchasing an additional 1,203 shares in the last quarter. Finally, Atlantic Union Bankshares Corp increased its position in shares of Haleon by 69.4% during the fourth quarter. Atlantic Union Bankshares Corp now owns 6,264 shares of the company’s stock worth $63,000 after purchasing an additional 2,567 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.